Abstract
Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
| Original language | English |
|---|---|
| Pages (from-to) | 13-15 |
| Number of pages | 3 |
| Journal | Journal of Chemotherapy |
| Volume | 3 |
| DOIs | |
| Publication status | Published - 1991 |
Keywords
- Antifungal Agents
- Fluconazole
- Geotrichum
- Microbial Sensitivity Tests
- Mitosporic Fungi
- Trichosporon
Fingerprint
Dive into the research topics of 'In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver